FR09C0047I2 - Preparation de produits de recombinaison immunogenes au moyen d'hydrates de carbone solubles actives par l'intermediaire de reactifs organiques de cyanylation - Google Patents

Preparation de produits de recombinaison immunogenes au moyen d'hydrates de carbone solubles actives par l'intermediaire de reactifs organiques de cyanylation

Info

Publication number
FR09C0047I2
FR09C0047I2 FR09C0047C FR09C0047C FR09C0047I2 FR 09C0047 I2 FR09C0047 I2 FR 09C0047I2 FR 09C0047 C FR09C0047 C FR 09C0047C FR 09C0047 C FR09C0047 C FR 09C0047C FR 09C0047 I2 FR09C0047 I2 FR 09C0047I2
Authority
FR
France
Prior art keywords
carbonhydrates
immunogenic
soluble
activated
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR09C0047C
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henry M Jackson Found For T
Original Assignee
Henry M Jackson Found For T
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/408,717 external-priority patent/US5651971A/en
Priority claimed from PCT/US1996/004013 external-priority patent/WO1996029094A1/en
Publication of FR09C0047I1 publication Critical patent/FR09C0047I1/fr
Application filed by Henry M Jackson Found For T filed Critical Henry M Jackson Found For T
Application granted granted Critical
Publication of FR09C0047I2 publication Critical patent/FR09C0047I2/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
FR09C0047C 1995-03-22 2009-09-24 Preparation de produits de recombinaison immunogenes au moyen d'hydrates de carbone solubles actives par l'intermediaire de reactifs organiques de cyanylation Active FR09C0047I2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/408,717 US5651971A (en) 1993-09-22 1995-03-22 Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents
US48266195A 1995-06-07 1995-06-07
PCT/US1996/004013 WO1996029094A1 (en) 1995-03-22 1996-03-22 Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents

Publications (2)

Publication Number Publication Date
FR09C0047I1 FR09C0047I1 (en, 2012) 2009-06-11
FR09C0047I2 true FR09C0047I2 (fr) 2017-03-17

Family

ID=41360971

Family Applications (1)

Application Number Title Priority Date Filing Date
FR09C0047C Active FR09C0047I2 (fr) 1995-03-22 2009-09-24 Preparation de produits de recombinaison immunogenes au moyen d'hydrates de carbone solubles actives par l'intermediaire de reactifs organiques de cyanylation

Country Status (5)

Country Link
JP (1) JP5594612B2 (en, 2012)
KR (1) KR100417183B1 (en, 2012)
DE (2) DE122009000055I1 (en, 2012)
FR (1) FR09C0047I2 (en, 2012)
NL (2) NL300414I1 (en, 2012)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2836153C (en) * 2009-12-17 2016-06-21 Fina Biosolutions, Llc Chemical reagents for the activation of polysaccharides in the preparation of conjugate vaccines

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE343210B (en, 2012) * 1967-12-20 1972-03-06 Pharmacia Ab
US4496538A (en) * 1982-07-06 1985-01-29 Connaught Laboratories, Inc. Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine
DE3541186A1 (de) * 1985-11-21 1987-05-27 Boehringer Mannheim Gmbh Wasserloesliche, stabilisierte peroxidasederivate, verfahren zu ihrer herstellung und verwendung zur bestimmung von wasserstoffperoxid
DE69012747T2 (de) * 1989-11-15 1995-03-16 Sandoz Ag Polymyxinkonjugate.
WO1992016232A1 (en) * 1991-03-12 1992-10-01 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Polysaccharide-protein conjugates
JP3917172B2 (ja) * 1992-02-11 2007-05-23 ヘンリー エム．ジャクソン ファウンデーション フォー ザ アドバンスメント オブ ミリタリー メディスン 二重担体の免疫原性構成体
JPH08504210A (ja) * 1992-12-07 1996-05-07 マガイニン ファーマシューティカルズ，インク． 結合生物活性ペプチドを使用した敗血症性ショックの治療

Also Published As

Publication number Publication date
NL300414I1 (nl) 2009-12-01
FR09C0047I1 (en, 2012) 2009-06-11
KR19980703201A (ko) 1998-10-15
DE122009000056I1 (de) 2010-01-28
JP5594612B2 (ja) 2014-09-24
NL300413I1 (nl) 2009-12-01
KR100417183B1 (ko) 2004-05-31
JP2012116850A (ja) 2012-06-21
DE122009000055I1 (de) 2009-12-31

Similar Documents

Publication Publication Date Title
DE69612198D1 (de) Eine impfstoffzusammensetzung,bestehend aus einem polysaccharid antigen-konjugatadsorbiert an aluminiumphosphat
IL113817A0 (en) Polynucleotide vaccine for papillomavirus pharmaceutical compositions containing it and a method for its use
LU92153I2 (fr) Teduglutide sous toutes ses formes, telles qu'elles sont protégées par le brevet de base
FR2817912B1 (fr) Reducteur reprenant les efforts axiaux generes par la soufflante d'un turboreacteur
EP0372466A3 (en) 2-amino-4 or 5-methoxycyclohexyl amides useful as analgesics
AU4741997A (en) Oral administration of chicken yolk antibodies to treat disease
FI963786L (fi) Uusia 1,4-disubstituoituja piperidiinijohdannaisia, jotka ovat käyttökelpoisia glutamaattireseptoriin vaikuttavina lääkeaineina
NZ333226A (en) Immunstimulating lipid formulation
FR09C0047I2 (fr) Preparation de produits de recombinaison immunogenes au moyen d'hydrates de carbone solubles actives par l'intermediaire de reactifs organiques de cyanylation
HUP0002724A3 (en) Clasto-lactacystin betha-lactone, analogs and intermediates thereof, process for their preparation and pharmaceutical compositions containing them
AU5992198A (en) Novel arylpiperazine derived from piperidine as antidepressant medicines
EE200000129A (et) Asendatud 1,2,3,4,5,6-heksahüdro-2,6-metano-3-bensasotsiin-10-oolid, nende valmistamise meetod ja kasutamine ravimitena
PT84399B (en) Process for the preparation of pharmaceutical compositions containing sodium 2-(2,6-dichloroanilino) phenylacetate
FI974435L (fi) Menetelmä 2,4-diklooripyridiinien muuttamiseksi 2-aryylioksi-4-klooripyridiineiksi
NO981070D0 (no) Benzotiofener-2-karboksamider-S,S-dioksider anvendt for forhindring av begroing
CO4910113A1 (es) Composiciones farmaceuticas estabilizadas, a base de quinu- pristina y de dalfopristina y su preparacion
RU97120940A (ru) Пептид, обладающий иммуномодулирующей активностью, и препарат на его основе
AU630186B2 (en) Canine corona virus vaccine
DK0579785T3 (da) Substituerede benzhydrylaminer som tlslutningsmolekyler til fastfasepeptidsyntese
SE8704240L (sv) Analgetiska preparat
FR2731355B1 (fr) Nouveaux immunogenes, nouveaux anticorps, procede de preparation et compositions pharmaceutiques les renfermant
ITRM950209A0 (it) Vaccino per la profilassiimmunitaria dell'infezione da virus della immunodeficienza felina del gatto domestico.
FR2583049B1 (fr) Produits resultant de la conjugaison d'un support macromoleculaire, d'un haptene et d'un muramyl-peptide par l'intermediaire d'un groupement substituant la partie saccharidique du muramyl-peptide et compositions selectivement immunogenes contenant ces produits
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
ATE42743T1 (de) Thiochromanderivat, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzungen.